New Milestones in Late-Stage Milestone Payments
We review late-stage development milestone fees paid from 2004 on, including some of the largest milestone payments yet made.
You may also be interested in...
We list the ranges and averages of payments that have been paid over the past five years at common regulatory milestones.
Perrigo’s clinical trials on CBD likely will take years before resulting products help bring order to the market. During earnings presentation, CEO Murray Kessler says the trials aren’t intended to establish claims for CBD but are more a long-term effort to provide data to FDA.
As draft guidance receives OMB review, FDA’s determination of no economic significance reflects its official position that the thousands of supplements, food and personal care products containing CBDs available in the US are unlawful.